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ABSTRAT
Background: Extraskeletal osteosarcoma (EOS), a rare variant of osteosarcoma (OS), is a malignant neoplasm that develops in 
soft tissues without primary bone involvement. This study aims to describe a case of EOS with a mediastinal location in a canine.
Case: A 10-year-old male Uruguayan Cimarron dog, was presented to the Laboratório Regional de Diagnóstico, Faculdade 
de Veterinária, Universidade Federal de Pelotas (LRD/FV/UFPel) for necropsy. The dog had a history of submandibular 
swelling, progressive hind limb paralysis, muscle atrophy, and breathing difficulties. During necropsy, in the thoracic cavity, 
approximately 900 mL of serosanguinous exudate and a reddish-brown, bossed mediastinal mass measuring 15.0 cm in the 
longest axis were also noted. The lung exhibited multifocal to coalescent, white, firm nodules extending from the pleura 
to the parenchyma and measuring up to 4.5 cm in diameter. In the parietal and occipital region of the brain, a matte wine 
mass measuring 2.3 cm in the longest axis was observed. Fragments of the neoplastic mass, organs of the abdominal and 
thoracic cavities, and the brain were harvested and fixed in 10% buffered formalin. After 48 h, the samples were routinely 
processed, incorporated in paraffin, cut into 3 µm-thick sections, and stained using Hematoxylin and Eosin (HE). Selected 
sections of the neoplasm, the lung, and the brain were subjected to Von Kossa staining and immunohistochemical (IHC) 
analysis. For IHC, primary anti-cytokeratin monoclonal antibodies (clone AE1 / AE3, BioCare Medical) at a 1:100 dilu-
tion, vimentin (clone V9, BioCare Medical) at a 1:100 dilution, S100 Protein (clone 15E2E2, BioCare Medical) at a 1:100 
dilution, and Ki67 (SP6 clone, BioCare Medical) at a 1:50 dilution were used. Immunostaining was visualized using 3-3’ 
diaminabenzidine (DAB). Histological evaluation of the mediastinal mass, the pulmonary nodules, and the central nervous 
system among polygonal mesenchymal cells was conducted. Marked pleomorphism with euchromatic, rounded to oval 
nuclei, evident nucleoli, and poorly delimited eosinophilic cytoplasm. Neoplastic cells were arranged in nests and bundles 
with an invasive growth pattern. Osteoid and bone matrix formation as well as multinucleated giant cells of the osteoclast 
type were observed. The bone matrix was better evidenced in Von Kossa staining. IHC in all analyzed sections of the 
neoplastic cells showed positive immunostaining for Vimentin and Ki67. In the sections incubated with anti-cytokeratin 
and S100 protein antibodies showed no presence of neoplastic cells.
Discussion: The diagnosis of EOS was based on the absence of primary bone lesions during microscopic necroscopy and 
on the exclusion of other histogenetic origins using IHC. The absence of primary bone lesions was the main attribute that 
differentiates EOS from other variants osteosarcomas, such as central/medullary and surface OS (periosteal and paraosteal) 
most frequently in canine species. The origin of EOS is uncertain. However, its occurrence has been originated with in 
pluripotent cells or previous injuries, such as retention of surgical sponges and vaccination sites. In this case, since the 
animal had no clinical history of injuries or surgical procedures that could induce the formation of a mediastinal neoplasm, 
the probable origin of the neoplasm was pluripotent cells. In dogs, EOS occurs mainly in the mammary glands, digestive 
system, liver, spleen, and subcutaneous tissue. Furthermore, the mediastinal location observed in this study was described 
only in goats. The clinical signs are nonspecific and varies with the location of the tumor, as observed in the present report. 
EOS may also present mediastinal location in the canine species. Necropsy, histopathological examination, and IHC were 
essential to establish the diagnosis of this OS variant.
Keywords: osteosarcoma, mesenchymal neoplasm, mediastinal tumor.
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INTRODUCTION
Extraskeletal osteosarcomas (EOS) are malig-
nant neoplasms of mesenchymal origin and are cha-
racterized by the production of osteoid. They develop 
in soft tissues without primary bone involvement, 
representing a rare variant of osteosarcoma (OS) in 
all species. In dogs, it corresponds to < 1% of OS 
diagnoses [13,16]. 
EOS are locally invasive and highly metastatic 
neoplasms, with lung metastasis occurring in 90% of 
cases. The prognosis is unfavorable with an average 
survival of 2 months after diagnosis [2,4,6,10]. The 
aim of this study was to report a case of EOS with a 
mediastinal location in a canine.
CASE 
A 10-year-old male Uruguayan Cimarron dog, 
was referred to the Laboratório Regional de Diagnóstico, 
Faculdade de Veterinária, Universidade Federal de Pe-
lotas (LRD/FV/UFPel) for necropsy. The dog had a his-
tory of submandibular swelling, progressive hind limb 
paralysis, muscle atrophy, and breathing difficulties. 
During necropsy, marked subcutaneous edema 
was observed in the submandibular region and the tho-
racic limbs. In the thoracic cavity, approximately 900 
mL of serosanguinous exudate and a reddish-brown, 
bossed mediastinal mass measuring 15.0 cm in the 
longest axis were also noted. When cut, the tumor was 
white, lobulated, with yellowish necrotic regions and 
with firm to ebony areas. The lung exhibited multifocal 
to coalescent, white, firm nodules extending from the 
pleura to the parenchyma and measuring up to 4.5 cm 
in diameter (Figure 1A). In the parietal and occipital 
region of the brain, a matte wine mass measuring 2.3 
cm in the longest axis was observed (Figure 1B).
Fragments of the neoplastic mass, organs of 
the abdominal and thoracic cavities, and the brain were 
harvested and fixed in 10% buffered formalin. After 
48 h, the samples were routinely processed, incorpo-
rated in paraffin1, cut into 3 µm-thick sections, and 
stained using Hematoxylin and Eosin (HE)2. Selected 
sections of the neoplasm, the lung, and the brain were 
subjected to Von Kossa3 staining and immunohistoche-
mical (IHC) analysis. For IHC it were  used: primary 
anti-cytokeratin4 monoclonal antibodies (clone AE1 
/ AE3) at a 1:100 dilution, vimentin4 (clone V9) at a 
1:100 dilution, S100 Protein4 (clone 15E2E2) at a 1:100 
dilution, and Ki674 (clone SP6) at a 1:50 dilution. Im-
munostaining was visualized using 3-3’ diaminaben-
zidine (DAB)5. The sections were counterstained with 
Harris hematoxylin2. As a negative control for each 
case, a section of the analyzed tissue was incubated 
only with the antibody diluent, Phosphate Buffered 
Saline (PBS)4.
Histological evaluation of the mediastinal 
mass, the pulmonary nodules, and the central nervous 
system among polygonal mesenchymal cells was 
conducted. Marked pleomorphism with euchromatic, 
rounded to oval nuclei, evident nucleoli, and poorly 
delimited eosinophilic cytoplasm were observed. In 
addition, 3-4 mitotic figures per field with the highest 
magnification (40×) were also noted. Neoplastic cells 
were arranged in nests and bundles with an invasive 
growth pattern. Osteoid and bone matrix formation as 
well as multinucleated giant cells of the osteoclast type 
were observed. Neoplastic emboli in the lymphatic 
vessels, areas of necrosis, and hemorrhage were also 
observed (Figure 2A and 2B).
IHC in all analyzed sections of the neoplastic 
cells showed positive immunostaining for Vimentin 
and Ki67 (Figure 3A and 3B), with Ki67 showing 
strong positive markings of osteoclastic giant cells. 
In contrast, sections incubated with anti-cytokeratin 
and S100 protein antibodies showed no presence of 
neoplastic cells (Figure 3C and 3D).
DISCUSSION
In this report, the diagnosis of EOS was based 
on the absence of primary bone lesions during mi-
croscopic necroscopy and on the exclusion of other 
histogenetic origins using IHC. The absence of primary 
bone lesions is the main attribute that differentiates 
EOS from frequently occurring osteosarcomas, such 
as central/medullary and surface OS (periosteal and 
paraosteal) [16]. Furthermore, nuclear scintigraphy, 
whole body radiography, and/or necropsy are the main 
diagnostic tools used to investigate the presence of 
bone lesions in suspected cases of EOS [14,16].
Central and surface OS occur mainly in the 
appendicular skeleton and are more prevalent in large 
and giant canine breeds [16]. This prevalence is related 
to the high mitotic activity of the metaphyseal growth 
plate and to bone cell mutations secondary to traumatic 
events due to high regional impact [4,16]. The origin 
of EOS is uncertain. However, in some cases, its oc-
currence has been associated with previous injuries, 
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Figure 1. Metastases extraskeletal osteosarcoma in a dog. A- Lung with white, multifocal nodules on the pleural surface (arrow) and a large mediastinal 
mass with a reddish-white, bossed surface (arrowhead). B- Brain with wine and matte area in the region of the parietal and occipital cortex.
Figure 2. Histopathology of extraskeletal osteosarcoma in a dog. A- Mediastinal neoplasm with cellular proliferation (*) and large amounts of bone 
trabeculae (arrow) [HE; 4x]. Giant osteoclast cells (arrow) in the middle of pleomorphic and polygonal cells [HE; 40x]. B- Von Kossa staining showing 
the bone matrix [10x].
such as retention of surgical sponges and vaccination 
sites [12,14]. In contrast, EOS can still originate in 
pluripotent cells. In many cases, the location of its 
occurrence is not related to previous lesions [11]. In 
this case, since the animal had no clinical history of 
injuries or surgical procedures that could induce the 
formation of a mediastinal neoplasm, the probable 
origin of the neoplasm was pluripotent cells. 
The highest occurrence of EOS is observed 
in Beagles and Rottweilers, with no predisposition 
for large and giant animals as observed in other OS 
variants [4,6,9]. Predisposition by sex is not observed 
in canines; however, studies that include OS of the 
mammary gland point to a higher occurrence in fema-
les than in males [8]. Additionally, the animal in the 
present case was also within the age group (10.4 years) 
more predisposed to developing EOS [8].
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In dogs, EOS occurs mainly in the mammary 
glands, digestive system, liver, spleen, and subcuta-
neous tissue [9], whereas in humans, in the lower extre-
mities. [10,13] and in cats, the orbit, liver, duodenum, 
and subcutaneous tissue [1,5,7,15]. Furthermore, the 
mediastinal location observed in this study was descri-
bed only in goats [3]. The clinical signs are nonspecific 
and varies with the location of the tumor. According to 
Langenbach et al. [9], EOS with dermal and subcuta-
neous locations have better prognoses than EOS with 
visceral locations, which is often imperceptible and 
leads to a late diagnosis made only during post mortem. 
In conclusion, we report a case of primary 
EOS with a mediastinal location in dogs. Necropsy, 
histopathological examination, and IHC were essential 
to establish the diagnosis of this OS variant.
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Figure 3. Immunohistochemical analysis of canine extraskeletal osteosarcoma. A- Mediastinal mass. Positive immunostaining of neoplastic cells 
for vimentin (arrows) [4x]. B- Mediastinal mass. Giant osteoclast cells with Ki67 immunostaining (arrows) [40x]. C- Lung. Cytokeratin-positive for 
bronchial epithelium (arrow) and negative for neoplastic cells (*) [10x]. D- Brain. Positive immunostaining of nerve cells for S100 Protein (arrow) and 
negative for neoplasm (*) [4x].
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